Eyenovia, Inc. announced on February 26, 2025, that it has been informed by The Nasdaq Stock Market LLC that the company has regained compliance with all Nasdaq Capital Market continued listing requirements.
This includes compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement rule, and Listing Rule 5810(c)(3)(A)(iii), the low priced stocks rule. The company attributed this achievement to its recent reverse stock split.
CEO Michael Rowe stated that maintaining the Nasdaq listing, along with other restructuring steps and accelerated development of the user-filled Optejet, represents important milestones. These actions support the ongoing evaluation of strategic alternatives and efforts to maximize shareholder value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.